StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a report released on Monday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Performance

China Pharma stock opened at $0.32 on Monday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.33 and a current ratio of 0.88. The stock’s 50 day simple moving average is $0.35 and its two-hundred day simple moving average is $0.45. China Pharma has a 12 month low of $0.27 and a 12 month high of $2.18.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.